Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingkailing Injection for Corticosteroid Withdrawal in RA
NCT02264301Unknown
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Aug 2014
- Primary completion
- Dec 2017
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Randomised trial of qingkailing in rheumatoid arthritis (RA) (2 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: Change from baseline in corticosteroids withdrawal rate at 24 weeks. Status: unknown.
02
Drugs
qingkailing
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02264301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02264301.